Calendar Astellas Pharma Inc.

Equities

4503

JP3942400007

Market Closed - Japan Exchange 02:00:00 2024-07-18 am EDT 5-day change 1st Jan Change
1,697 JPY +0.53% Intraday chart for Astellas Pharma Inc. +2.11% +0.65%

Chart calendar Astellas Pharma Inc.

2196dc160ccb2972f6edf85ea3cb6._NrE5Zt7j7tBw21I0s6p5l6eMsJsJYxbmx8VzTnT3lQ.t5CLtagp_u0rtBQKpKr6njDVeaUVQt0r9lNTq3iMvBvIjqWc_h_39CymCg~96c7d5cd37736ff08ef6bc1c3c2780fc

Upcoming events on Astellas Pharma Inc.

2024-08-01 02:00 am Q1 2024 Earnings Release
2024-08-01 03:00 am Q1 2024 Earnings Call
2024-10-30 Q2 2024 Earnings Release (Projected)
2025-01-29 Q3 2024 Earnings Release (Projected)
2025-04-23 Q4 2024 Earnings Release (Projected)
2025-08-04 Q1 2025 Earnings Release (Projected)

Past events on Astellas Pharma Inc.

2024-06-19 09:00 pm Annual General Meeting
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number : 8585
2024-06-03 09:00 am American Society of Clinical Oncology Meeting - Abstract Number : 4502
2024-06-03 09:00 am American Society of Clinical Oncology Meeting - Abstract Number : 4503
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : 5087
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : 5084
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : TPS6116
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : 4564
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : 4563
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number : 4562
2024-06-01 04:00 pm American Society of Clinical Oncology Meeting - Abstract Number : 5005
2024-06-01 04:00 pm American Society of Clinical Oncology Meeting - Abstract Number : 1005
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number : 4036
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number : 4046
2024-05-30 American Society of Clinical Oncology Meeting - Abstract Number : e23287
2024-05-30 American Society of Clinical Oncology Meeting - Abstract Number : e16547
2024-05-30 American Society of Clinical Oncology Meeting - Abstract Number : e17071
2024-04-25 04:00 am Q4 2023 Earnings Call
2024-04-25 02:00 am Q4 2023 Earnings Release
2024-04-08 Cell & Gene Meeting on the Med Conference

Past dividends on Astellas Pharma Inc.

2024-03-27 Final Payment 35 JPY
2023-09-27 Interim Payment 35 JPY
2023-03-29 Final Payment 30 JPY
2022-09-28 Interim Payment 30 JPY
2022-03-29 Final Payment 25 JPY
2021-09-28 Interim Payment 25 JPY
2021-03-29 Final Payment 21 JPY
2020-09-28 Interim Payment 21 JPY
2020-03-29 Final Payment 20 JPY
2019-09-26 Interim Payment 20 JPY

Annual results

Fiscal PeriodMarch 2020 2021 2022 2023 2024 2025
Net sales
Million JPY
Released
Forecast
Spread
1 300 843
1 274 827
2.04%
1 249 528
1 258 841
-0.74%
1 296 163
1 320 041
-1.81%
1 518 619
1 508 697
0.66%
1 603 672
1 571 972
2.02%

1 689 978

EBITDA
Million JPY
Released
Forecast
Spread
310 387
316 993
-2.08%
208 703
300 597
-30.57%
235 370
316 919
-25.73%
238 767
321 316
-25.69%
183 358
264 920
-30.79%

291 953

EBIT
Million JPY
Released
Forecast
Spread
243 991
257 148
-5.12%
136 051
221 342
-38.53%
155 686
219 051
-28.93%
133 029
183 181
-27.38%
25 518
89 542
-71.5%

109 250

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
245 350
262 926
-6.68%
145 324
219 749
-33.87%
156 886
214 703
-26.93%
132 361
187 029
-29.23%
24 969
24 853
0.47%

78 169

Net income
Million JPY
Released
Forecast
Spread
195 411
203 519
-3.98%
120 589
176 431
-31.65%
124 086
177 294
-30.01%
98 714
144 398
-31.64%
17 045
13 409
27.12%

58 179

EPS
JPY
Released
Forecast
Spread
104
113
-7.83%
64,9
96,5
-32.74%
67,1
94,2
-28.76%
54,2
80,3
-32.42%
9,51
13,2
-28.05%

34,5

Announcement Date14/05/2027/04/2127/04/2227/04/2325/04/24-

Quarterly results

Fiscal PeriodMarch 2021 S1 2022 S1 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4 2026 Q1 2026 S1
Net sales
Million JPY
Released
Forecast
Spread
615 480
631 150
-2.48%
651 666
653 900
-0.34%
303 870
324 327
-6.31%
381 791
345 350
10.55%
380 394
360 355
5.56%
762 185
748 000
1.9%
402 180
395 900
1.59%
354 254
361 045
-1.88%
374 990
357 906
4.77%
392 148
355 602
10.28%
767 138
714 088
7.43%
421 932
385 383
9.48%
414 602
381 093
8.79%

411 621


424 880


834 303


439 333


410 439


423 823


855 237

EBITDA
Million JPY
Released
Forecast
Spread

































70 087
123 700
-43.34%
42,0
59 200
-99.93%

79 800


64 400





87 500


61 700







EBIT
Million JPY
Released
Forecast
Spread
86 872
139 408
-37.68%
90 169
138 200
-34.75%
-13 685
41 432
-133.03%
33 147
47 625
-30.4%
86 744
75 977
14.17%
119 891
117 500
2.03%
61 388
83 350
-26.35%
-48 250
26 250
-283.81%
45 794
67 478
-32.14%
5 222
53 977
-90.33%
51 016
94 059
-45.76%
23 103
47 250
-51.1%
-48 601
18 027
-369.6%

38 921


44 544


82 698


58 115


-9 351


29 567


65 110

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
89 091
139 808
-36.28%
89 085
143 200
-37.79%
-10 516
41 300
-125.46%
31 679
48 800
-35.08%
88 801
95 700
-7.21%
120 480
115 500
4.31%
59 758
78 000
-23.39%
-47 877
27 200
-276.02%
46 850
66 704
-29.76%
5 328
52 133
-89.78%
52 178
93 959
-44.47%
21 452
54 767
-60.83%
-48 661
-57 900
15.96%

23 044


31 873


45 598


39 791


-28 018


27 817


61 610

Net income
Million JPY
Released
Forecast
Spread
72 838
110 808
-34.27%
71 609
113 700
-37.02%
-8 409
32 500
-125.87%
24 812
35 300
-29.71%
71 622
74 600
-3.99%
96 434
90 000
7.15%
48 405
60 800
-20.39%
-46 125
14 950
-408.53%
33 129
52 178
-36.51%
-1 459
42 300
-103.45%
31 670
71 261
-55.56%
18 653
40 467
-53.91%
-33 278
-44 000
24.37%

24 519


28 357


35 163


37 430


-6 658


20 585


45 592

EPS
JPY
Released
Forecast
Spread
39,2
54,5
-28.06%
38,7
61,4
-37.05%
-4,43
15,9
-127.89%
13,6
18,6
-27.03%
39,3
33,6
16.89%
52,9
46,6
13.45%
26,6
39,2
-32.31%
-25,2
-20,2
-24.61%
18,5
29,8
-38.06%
-0,80
23,9
-103.35%
17,7
41,1
-56.98%
10,4
15,2
-31.36%
-18,6
-8,52
-117.76%

10,2


14,4


17,4


21,2


-23,6


11,5


25,4

Announcement Date30/10/2029/10/2127/04/2201/08/2231/10/2231/10/2206/02/2327/04/2301/08/2301/11/2301/11/2305/02/2425/04/24-------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. Calendar Astellas Pharma Inc.